logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
30/08/2025
National Highway Traffic Safety Administration: Stellantis recalls over 219,000 U.S. market vehicles due to rearview camera issues.
Latest
8 m ago
According to the AI flash news, Minsheng Securities issued a research report on August 29th, giving TCL Technology (000100.SZ) a recommended rating. The main reasons for the rating include: 1) The stable position of the semiconductor display business, enhancing profitability internally and externally; 2) Pressure on TCL Huaxing's performance, with the domestic silicon wafer business leading domestically. (Daily Economic News)
12 m ago
Christmas supplies shipping "hot" Yiwu merchants rush to work "busy"
30 m ago
Heilongjiang's crystalline graphite reserves amount to 3.79 billion tons, ranking first in the country.
31 m ago
AstraZeneca: Baxidulten achieved the primary endpoint and all secondary endpoints in the BaxHTN Phase III trial. The 2mg dose of Baxidulten reduced systolic blood pressure by 15.7 mmHg compared to baseline levels. Baxidulten was generally well tolerated, and no unexpected safety issues were identified.
31 m ago
AstraZeneca: Baxdrosdat (Baxdrostat) met the primary endpoint and all secondary endpoints in the BaxHTN phase III trial. The 2 mg dose of Baxdrosdat reduced systolic blood pressure by 15.7 mmHg from baseline (9.8 mmHg after placebo correction). Overall, Baxdrosdat was well-tolerated with no unexpected safety issues.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.